Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20).
Ann Oncol. 2013 Oct;24(10):2694-2698. doi: 10.1093/annonc/mdt291. Epub 2013 Aug 13.
Ann Oncol. 2013.
PMID: 23942774
Free article.
Clinical Trial.
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma.
Weber JS, Dummer R, de Pril V, Lebbé C, Hodi FS; MDX010-20 Investigators.
Weber JS, et al.
Cancer. 2013 May 1;119(9):1675-82. doi: 10.1002/cncr.27969. Epub 2013 Feb 7.
Cancer. 2013.
PMID: 23400564
Free article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control.
Robert C, Schadendorf D, Messina M, Hodi FS, O'Day S; MDX010-20 investigators.
Robert C, et al.
Clin Cancer Res. 2013 Apr 15;19(8):2232-9. doi: 10.1158/1078-0432.CCR-12-3080. Epub 2013 Feb 26.
Clin Cancer Res. 2013.
PMID: 23444228
Clinical Trial.
Item in Clipboard
Cite
Cite